Products

Lycopodii Herba Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    • Product Name: Lycopodii Herba Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions
    • Alias: Clubmoss
    • Einecs: 273-383-5
    • Mininmum Order: 1 g
    • Factroy Site: Yudu County, Ganzhou, Jiangxi, China
    • Price Inquiry: admin@ascent-chem.com
    • Manufacturer: Ascent Petrochem Holdings Co., Limited
    • CONTACT NOW
    Specifications

    HS Code

    597832

    Product Name Lycopodii Herba Veterinary Grade API
    Intended Use Veterinary medicines such as tablets, injections, capsules, powders, granules, premix, and solutions
    Source Lycopodium clavatum (clubmoss) whole plant
    Appearance Yellowish green to greenish brown powder
    Active Compounds Alkaloids, flavonoids, triterpenoids, lignans
    Solubility Practically insoluble in water, soluble in ethanol and organic solvents
    Storage Conditions Store in a cool, dry, and well-ventilated place away from direct sunlight
    Shelf Life 2 years when stored under recommended conditions
    Purity Typically ≥98% by HPLC
    Functions Anti-inflammatory, diuretic, antibacterial, promotes urination and reduces swelling

    As an accredited Lycopodii Herba Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Lycopodii Herba Veterinary Grade API is packed in sealed 25kg fiber drums with inner double-layer plastic bags for product integrity.
    Shipping The Lycopodii Herba Veterinary Grade API is securely packaged in sealed, tamper-evident containers, suitable for tablets, injections, capsules, powders, granules, premix, and solutions. Shipped via air or sea freight under controlled temperatures with all regulatory documentation, ensuring product integrity during international or domestic transport.
    Storage Lycopodii Herba Veterinary Grade API should be stored in a cool, dry, and well-ventilated area, away from direct sunlight, heat, and moisture. Keep the container tightly closed and properly labeled. Store at room temperature, ideally below 25°C. Avoid exposure to incompatible substances and keep out of reach of unauthorized personnel, children, and animals. Follow local regulations for storage.
    Application of Lycopodii Herba Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions

    Applications of Lycopodii Herba Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions in Industrial Manufacturing

    Our veterinary grade Lycopodii Herba API serves as a key botanical extract in the formulation of pharmaceutical preparations for animal health. The following sections detail distinct downstream industrial application scenarios, ensuring compliance, precise dosage design, process integration, and end-product specification for international B2B partners.

    1. Veterinary Oral Tablets Manufacturing

    Pharmaceutical manufacturers utilize this material as an active component in the production of oral veterinary tablets, addressing mild inflammation and supporting urinary tract care in cattle and companion animals. The process involves direct compression techniques, where staff must maintain consistent particle size and moisture content to ensure uniform mixing. Regulatory documentation and validation occur at each batch, with traceability from raw extract to packaging. Customers typically select this extract for formulations targeting regulatory-monitored conditions, with close monitoring of API concentration by in-house QC.

    Industry compliance standards

    • Veterinary Pharmacopoeia of the People’s Republic of China (latest edition)
    • EU Regulation No. 2019/6 (veterinary medicinal products)
    • Good Manufacturing Practice (GMP) for Veterinary Medicinal Products (VICH GL)
    • US FDA 21 CFR Part 226: Current Good Manufacturing Practice for Type A Medicated Articles

    Typical usage ratio

    • 2.5% to 7% (w/w) of total tablet mass, adjusted by animal species, daily dosage, and target application; lower dose for small animals, higher for ruminants.

    Downstream process integration

    • Introduced during the dry blending phase before granulation and direct compression; uniform dispersion monitored by in-line NIR spectroscopy or HPLC assay.

    Final product types

    • Veterinary prescription tablets for cattle, swine, and canines, registered under veterinary medicine product lines.
    • Non-prescription pet supplement tablets for urinary tract support.
    • Monocomponent and multicomponent herbal veterinary tablets.
    • Traceable environmental health remediation tablets for livestock farms.

    2. Injectable Veterinary Solution Formulation

    API producers and CDMO partners select this extract for small-batch or mass production of sterile injectable solutions, offering anti-inflammatory or mild diuretic support for livestock in intensive farming environments. Formulations require delicate balance of solubilizer and stabilizer agents to retain herb activity. Special filtration, sterilization protocols (e.g., autoclave or membrane filtration), and sterile bottling ensure API integrity. Downstream customers validate incoming API by in-process potency, sterility, and trace alkaloid determination.

    Industry compliance standards

    • European Pharmacopoeia (Ph. Eur.) monographs for herbal injectable APIs
    • US FDA Guidance for Industry #152 for Sterile Drug Product Manufacturing
    • Chinese GMP for Veterinary Drug Production, sterile category requirements
    • ISO 9001:2015 for Process Control (applied to bulk injectable manufacturing)

    Typical usage ratio

    • 0.1%–0.5% (w/v) of solution; actual dosing varies by intended species, solution strength, and combination with other actives.

    Downstream process integration

    • Added to dissolving vessel post-filtration, immediately before final sterile filtration and aseptic filling; potency confirmed by in-line analytical HPLC.

    Final product types

    • Sterile multi-dose veterinary injectable vials
    • Single-use dosage ampoules for large animals
    • Combination injectable solutions for poultry and livestock
    • Critical care injectable products in veterinary hospitals

    3. Granular and Pelletized Feed Additive Production

    Feed manufacturers employ this plant extract as a value-added botanical ingredient in the production of medicated and functional animal feeds. Inclusion rates and granulation conditions differ according to target species (e.g., swine, poultry, aquaculture), and the finished feed’s intended claims under local animal nutrition guidelines. The material withstands pelleting and extrusion processes, provided the temperature and residence times do not damage the active fractions. Manufacturers implement incoming quality checks and traceability throughout the micronization and mixing line.

    Industry compliance standards

    • China GB/T 13078–2017 Hygienical standards for feeds
    • European Feed Additives Regulation EC 1831/2003
    • US FDA 21 CFR 573: Food Additives permitted in Feed and Drinking Water of Animals
    • FSMA (Food Safety Modernization Act) Animal Food Rule

    Typical usage ratio

    • 0.2% to 1.0% (w/w) in medicated feed; precise ratio set by animal daily feed intake, veterinary prescription, and local feed additive laws.

    Downstream process integration

    • Mixed during the pre-conditioning stage ahead of pelleting; distributed evenly through the micro-ingredient dosing system and verified by batch sampling and LC/MS analysis.

    Final product types

    • Medicated feed pellets for cattle and swine
    • Functional poultry crumbles and mash blends
    • Granular premixes for aquaculture
    • Pet nutrition supplement blends

    4. Veterinary Capsule Filling Operations

    Pharmaceutical contract manufacturers use this extract in powder-filled veterinary capsules, targeting therapeutic indications approved by local authorities. Manufacturers must validate API purity and homogeneity before encapsulation with hard gelatin or HPMC shells. Gelatin type, fill weight, and blend properties are controlled to prevent stratification. Final fill is routinely tested for uniformity and dissolution profile against release standards. Customers often require documentation linking each batch to quality-release and animal safety records.

    Industry compliance standards

    • Chinese Veterinary Drug Administration Law (latest revision)
    • US FDA Guidance to Industry: Size, Shape, and Physical Attributes of Generic Capsules
    • European Union EudraLex Vol. 4, Part II GMP for APIs
    • Pharmacopoeia of Japan for veterinary capsules (where applicable)

    Typical usage ratio

    • 1.5% to 5% (w/w) per capsule fill; adjusted for target animal weight and daily dosage schedule. Lower rates for small companion animals, higher for production livestock.

    Downstream process integration

    • Homogenized with bulking excipients and flow agents, filled directly by automated capsule fillers; blend uniformity tested by sample extraction and UPLC analysis.

    Final product types

    • Veterinary prescription capsules for dogs, cats, and horses
    • Combination herbal-chemical API capsules
    • Nutritional supplement capsules for exotic animal husbandry
    • Batch-labeled, serialized capsule bottles for regulated veterinary markets

    5. Water-Soluble Powdered Additive for Large-Scale Livestock Treatment

    Feedlot operators and animal health solution providers formulate water-soluble powder sachets using this extract for mass treatment or preventive health protocols in farm animals. Formulators must guarantee rapid dispersion and solubility, with attention to compatible stabilizers and carrier excipients. Production lines closely monitor particle fineness and moisture to avoid caking in bulk transport or storage. Dosage strategy adapts to regional veterinary recommendations and system delivery requirements, with traceability to farm-level application.

    Industry compliance standards

    • Codex Alimentarius Guidelines for Veterinary Drug Residues
    • China Veterinary Drug GMP (2020 Revised Edition)
    • EU Feed Hygiene Regulation EC 183/2005
    • US FDA Center for Veterinary Medicine (CVM) bulk powder approval standards

    Typical usage ratio

    • 0.5% to 2% (w/w) in final premix; adjusted for end-use dilution, drinking water concentration, and duration of administration periods.

    Downstream process integration

    • Blended with soluble carriers and anti-caking agents during powder preparation; final formulation passes through sieving and micro-encapsulation lines for stability.

    Final product types

    • Poultry and swine water-soluble therapeutic powder sachets
    • Large-animal farm dissolving powders for herd treatment
    • Packaged bulk powder additives for veterinary clinics
    • Custom pre-measured solution pouches for automated livestock dosing systems

    Free Quote

    Competitive Lycopodii Herba Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.

    We will respond to you as soon as possible.

    Tel: +8615365186327

    Email: admin@ascent-chem.com

    Get Free Quote of Ascent Petrochem Holdings Co., Limited

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Lycopodii Herba Veterinary Grade API: Meeting Modern Animal Health Needs

    Introduction to Lycopodii Herba in Veterinary Use

    In the heart of every successful animal healthcare product, you’ll find the genuine effort that starts at the level of ingredients, and no ingredient brings a deeper legacy to the table than Lycopodii Herba. For us as the manufacturer, what sets this botanical apart isn’t just its ancient roots or botanical lineage—it’s the proof we find every day in the real world with livestock health and product development.

    Factories and research wings work together to bring out the best from Lycopodii Herba, sourced and processed exclusively for use as an active pharmaceutical ingredient (API) for veterinary applications. We’ve watched it serve needs ranging from respiratory health to mild digestive issues, and the consistent demand from veterinarians tells its own story.

    The path from herb to high-purity API starts with careful sourcing. Properly grown Lycopodii Herba keeps valuable alkaloids and polysaccharides intact. Unlike those who trade on label value, we take each batch from controlled cultivation, clean harvest, and direct processing. No extra hands, no guessing about what’s inside. This makes all the difference when you’re manufacturing high-volume tablets, injections, capsules, or even premix blends.

    Usage Across Veterinary Formulations

    Pharmaceutical engineers in the veterinary sector seek APIs that flow cleanly from bench to batch. Lycopodii Herba’s dried powder and refined extract forms drive steady results in granular and powder blends, and they bind well in compressed tablet lines. Its stability under gentle drying and low-temperature extraction enables our plant-based actives to retain potency, an aspect we constantly monitor from lot to lot.

    For injectables and solution-based applications, solubility and particle size can impact end-dose consistency in animals. Our facility tailors the cut and micronization to fit direct solubilization in veterinary saline or oil-based carriers. When you assemble a batch of oral premix or add powder to a pelleted feed, the goal is for every serving an animal receives to contain a shot of botanical support—without fillers, without question marks on purity.

    It’s common in this industry to see extracts traded on international markets declared as “veterinary grade.” Yet, these tags rarely guarantee the API passes tests relevant for injectable or compounded feed uses. Veterinary standards differ sharply from ordinary OTC herbal products. Every kilo processed here runs through specs supporting low heavy metals, pesticide residue freedom, and batch-level traceability. With years of process optimization, our runs avoid solvent residues often left behind by less controlled methods.

    Specifications and Quality Attributes that Matter

    Chemists and veterinarians regularly meet at the crossroad of pure tradition and regulatory scrutiny. We address this by anchoring our manufacturing around pharmaceutical norms—clean extraction, particle size that fits the application, and microbial control that passes veterinary import screens. The natural content of Lycopodium alkaloids and polysaccharides serves as a fingerprint; when you unlock a drum at the next plant, it should perform batch after batch. Any deviation tells us to stop and rework the process.

    The typical product that leaves our plant arrives in fine powder or concentrated extract, with specifications customized to match tablet compression, oral solution blending, or pre-mix addition for mass medication. Moisture content and identity tests line up with each batch release, and chemotype identification gives confidence to regulatory inspectors.

    We sidestep powdered blends that lean heavily on bulking agents or unnecessary carriers. The veterinary applications we serve don’t work well with dilute actives—the focus needs to stay on the herbal payload, not what’s bulking the drum. Some firms push high-purity claims by over-processing, but we have found a balance in maintaining the integrity of active fractions while keeping bioburden in check. By keeping process steps transparent, you can track every movement from raw plant to finished API.

    Differences from Conventional Lycopodii Herba Products

    One of the loudest gripes we hear from veterinary end-users comes from confusion in raw material origin and labeling. Standard herbal powders, traded for years across herbal markets, focus almost entirely on price and color—not on composition or consistency. Cheap material often contains plant parts or adulterants, which may satisfy a dietary supplement market but creates problems in medicated premixes.

    Our run of Lycopodii Herba takes only core, approved plant parts, and every harvest ties to documented origin fields. No farm substitution, no accidental inclusion of similar-looking wild plants. Lapses in the chain of custody risk contamination, and those sorts of shortcuts might get missed entirely by distributors or resellers but won’t be tolerated in our process.

    On several occasions, we’ve tested third-party products described as veterinary grade, only to find discrepancies in alkaloid levels or test failures on micro standards. From these lessons, our product never presses for maximum yield at the cost of safety or label accuracy. The final API reflects actual secondary metabolites found in authentic Lycopodii Herba, not those stretched by carrier fillers or solvent residues.

    Real-World Impact on Veterinary Outcomes

    Veterinary practitioners give us direct feedback: from clinics and feedlots, the expectation is simple—does the API perform consistently in formulations made at scale, and can it be trusted even with sensitive species? Repeated field use in large-animal medicine has shown that precise origins and high traceability matter more than marketing promises.

    Certain client sites rely on Lycopodii Herba for chronic pulmonary support in livestock. They report flare-ups when switching to lower-quality inputs, confirming that not all botanicals bearing the same binomial give the same practical benefit. One example came from a line of tablets made for an injectate alternative—the old supplier delivered seasonal product swings, disrupting both shelf life and response in the animal.

    Switching to our consistently processed API, our client saw not only regulatory confidence but stable tablet-making, predictable results, and improved tolerance. Key markers—like alkaloid content—stay inside validated bands, letting the formulator fine-tune a dose without second-guessing the plant base.

    The Foundation of Careful Sourcing

    Nothing in botanical manufacturing can replace clean, reliable fields and tight upstream stewardship. Our growers avoid generic wild-collection practices that can allow adulterants and crop contamination. This commitment shapes the API quality long before extraction begins. Regular site visits and contracts with dedicated farmers give us raw material that is both potent and jobs-protective for the local workforce.

    Over years, we’ve learned the pitfalls that arise from fast, price-driven trading—mix-ups in plant species, storage in unsuitable conditions, and a host of risks that might only show up months later in finished feed or medicine. Careful selection pays its dividends not just at inspection, but in the daily feedback from veterinarians coping with real animals, not just numbers on a COA sheet.

    Technical Manufacturing Advantages

    With a strong laboratory backbone, every run of our Lycopodii Herba API circles through spectral identity checks, heavy metal screens, and residue analyses. We’ve adapted methods from both the traditional botanical sector and the tighter confines of pharma manufacturing, so the transition from powder into tablet, liquid, or granular blend works without headaches.

    Thermal handling remains a challenge, but our engineers use indirect drying below 45°C and multi-stage screening to retain the active fractions. Typical bulk density is adjusted to fit both capsule production (flow properties) and high-speed tableting without causing machine fouling or inconsistent weights. We’ve run head-to-head tests with third-party APIs in our own test facility; consistent output and fewer out-of-specification lots reinforce our manufacturing controls.

    Some of our work supports pharmaceutical partners who prefer liquid suspensions or low-particle premixes. Here, particle size and residue limits make a tangible difference in blending and end-use palatability. From mixing with vitamin blends to direct zoo and livestock applications, the goal always remains to preserve key active markers through steady process inputs.

    Navigating Regulatory Demands

    Contemporary veterinary practice faces mounting regulatory oversight. Our site has opened its doors to inspections from both local and international governments focused on cross-border trade in active pharmaceutical ingredients. From the start, we design each step of the Lycopodii Herba journey to align with GMP standards specific to veterinary APIs.

    Whether we’re bulk shipping to integrators or prepping batch-size releases for specialty compounding, each lot links directly to qualified release, and electronic batch records further support audit needs. Our documentation supports shelf-life claims with stability studies and backs up residue testing with real-world validation, not just laboratory promises. The target is always clear: uncompromised compliance so veterinarians and downstream processors can pass their own regulatory scrutiny without concern.

    As we navigate changes in international import restrictions or shifts in accepted analytical standards, our quality team maintains dialogue with veterinary regulatory authorities. When authorities call for improvements, our processing lines adapt to reduce solvent residues or lower allowable microbe content. This flexibility allows our clients—whether tabletters, compounders, or feed-blenders—to adapt formulations or package configurations with assurance the API stays in sync with any new standard.

    Integrating with Pharmaceutical and Feed Industry Partners

    Many of our closest relationships have been forged with partners in both animal pharma and veterinary feed additive sectors. These end-users come to us with highly specific requests—on alkaloid profiles, moisture levels, or packing formats, knowing our knowledge base covers both plant biology and mechanical process constraints.

    A repeated area of feedback focuses on the cost of regulatory missteps and batch rejections. While some in the supply chain chase market prices down, we hear direct from partners that trusted, specification-driven supply eliminates rework, recall risks, and regulatory fines. Reliability beats price cutting every time.

    We’ve also supported pilot launches where clients needed pre-blended APIs custom-sized for their own process. Batch-level segmentation, customized packaging for contamination control, and rapid lot release enable research-focused clients to scale up without process surprises.

    Innovation in Lycopodii Herba API—Ongoing Research

    Scientific inquiry never rests, and neither does our effort to refine Lycopodii Herba API for evolving veterinary needs. In cooperation with academic partners, pilot trials with microencapsulation and novel solvent-free extraction are underway, aiming for increased intestinal bioavailability and easier administration in feed and oral dosages.

    We are testing low-particle suspensions and immediate-release coating technologies for better taste masking and flow in multi-herb veterinary mixtures. Early work points to better swallowing acceptability in young and sensitive animals, an outcome only possible with APIs free from ingredient drift and unexpected plant fractions.

    Much of this research also focuses on environmental impact. Clean extraction technologies developed in-house reduce waste water volume and eliminate hazardous solvent cycles. Feedback from field veterinarians on side effects or unexpected reactivity feeds back into our own planning, leading to continual adjustments in plant handling and process refinement.

    Meeting Tomorrow’s Veterinary API Challenges

    We know the landscape is shifting fast. The world’s appetite for safe, plant-driven APIs intensifies as concerns about residue levels, animal health, and existing pharmaceutical failures rise. Supply chains stretch longer, regulations thicken, and customer education ramps up.

    Our answer lies not in lowest-cost, bulk-only production, but in closer ties with those who actually use our API. Regular field visits, cooperative formulation trials, and direct troubleshooting help maintain quality at every link in the chain. We keep an open mind to adjusting our specifications for new administration routes or formulations, informed by what actually works, not just what’s demanded on a labeling checklist.

    Over the past decade, our team has seen products once branded for human herbal use try to move into animal health spaces, often without adequate process control. We’ve responded by securing tighter harvest-to-extract pipelines and putting active traceability before speed to market.

    Efforts here have practical rewards—farmers, veterinarians, and pharmaceutical packagers all report fewer returns, steadier dosing outcomes, and clearer regulatory paths. While the plant itself remains unchanged, the journey from root to drum needs precision and care not often reflected in cheaper imports or broadly labeled store-bought blends.

    A Commitment to Continuous Improvement

    Every step in the process reflects a choice to build trust—not with slogans or promises, but with outcomes. From sourcing in fields untouched by market-driven swaps, to final drum release, the focus always returns to safety, traceability, and fitness for purpose in real-world practice.

    Clients expect not only a quality certificate but the confidence that each kilo meets GMP-informed manufacturing steps and supports efficacy in their own finished veterinary products. We know expectations shift each year, and so does our investment in people, machinery, agronomy, and direct veterinary feedback.

    The reality is, manufacturing veterinary grade Lycopodii Herba API is not a matter of routine—it requires constant dialogue with the people and animals it is ultimately meant to serve. With each batch, we reaffirm our commitment to trusted production, clear traceability, and flexible response to tomorrow’s needs.

    Top